Beqiri, Erta
García-Orellana, Marta
Politi, Anna
Zeiler, Frederick A.
Placek, Michal M.
Fàbregas, Neus
Tas, Jeanette
De Sloovere, Veerle
Czosnyka, Marek
Aries, Marcel
Valero, Ricard
de Riva, Nicolás
Smielewski, Peter
Funding for this research was provided by:
Gates Cambridge Trust
Medical Research Council (MR N013433-1)
Manitoba Public Insurance (MPI) Professorship in Neuroscience
Natural Sciences and Engineering Research Council of Canada
Canadian Institutes of Health Research
MPI Neuroscience Research Operating Fund
Health Sciences Centre Foundation Winnipeg
Canada Foundation for Innovation
Research Manitoba (3906, 5429)
the University of Manitoba VPRI Research Investment Fund
HersenStrijd fonds, Maastricht
Article History
Received: 27 August 2023
Accepted: 23 November 2023
First Online: 19 January 2024
Declarations
:
: Peter Smielewski and Marek Czosnyka receive part of the licensing fees for ICM + software, licensed by Cambridge Enterprise Ltd, University of Cambridge, Cambridge.
: Ethical approval for this retrospective study (Ethical Committee HCB/2018/1173) was provided by the Ethics committee of Research with Medicines of the Hospital Clinic de Barcelona, Barcelona, Spain (Chairperson Begoña Gómez Pérez) on 21st December 2018. Written informed consent was waived by the Ethics Committee.
: Written informed consent was waived by the Ethics Committee.
: Not applicable.